@article{oai:nagasaki-u.repo.nii.ac.jp:00026603,
 author = {Komatsu, Nahoko and Shimada, Takako and Higashijima-Nagata, Ai and Ohashi, Kazuaki and Abe, Syuhei and Miura, Kiyonori},
 issue = {1},
 journal = {Acta medica Nagasakiensia},
 month = {Jun},
 note = {Cytomegalovirus (CMV) colitis associated with chemotherapy for gynecologic cancer is rare. We report a case of CMV colitis linked to treatment with paclitaxel/carboplatin (TC) and bevacizumab (BEV) for ovarian cancer. Our patient was a 59-year-old woman who completed one course of TC chemotherapy and one course of TC + BEV as neoadjuvant chemotherapy for advanced ovarian cancer. On the 7th day of TC + BEV therapy, she visited our hospital for continuous diarrhea, abdominal pain, and melena. Grade 4 neutropenia and fever were also detected. She was diagnosed as CMV colitis via colonoscopy and histopathological examination. This is the first case report of CMV colitis complicated by chemotherapy-induced febrile neutropenia during the treatment for gynecologic cancer., Acta medica Nagasakiensia, 65(1), pp.17-19; 2021},
 pages = {17--19},
 title = {Cytomegalovirus (CMV) colitis associated with chemotherapy and molecular targeted therapy for gynecologic cancer: A case report of ovarian cancer},
 volume = {65},
 year = {2021}
}